Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. Juni 2016 12:30 ET | Quelle: OpGen, Inc.

OpGen Highlights Strong Performance of Acuitas® Resistome Test at ASM Microbe 2016

GAITHERSBURG, Md., June 20, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, today...
20. Mai 2016 10:14 ET | Quelle: OpGen, Inc.

OpGen Announces Closing of $10 Million Private Placement

GAITHERSBURG, Md., May 20, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, announces...
17. Mai 2016 09:00 ET | Quelle: OpGen, Inc.

OpGen Supports New White House National Microbiome Initiative

GAITHERSBURG, Md., May 17, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a leading developer of precision medicine tools to combat infectious disease in global healthcare settings, supports...
12. Mai 2016 16:01 ET | Quelle: OpGen, Inc.

OpGen Reports 2016 First Quarter Financial Results and Business Update

First quarter revenue increases 128% over prior year to $1.1 million First U.S. citywide quantification of Superbug pathogens completed in District of Columbia Announced pricing of $10.4 million...
12. Mai 2016 09:00 ET | Quelle: OpGen, Inc.

OpGen Announces Pricing of $10 Million Private Placement

GAITHERSBURG, Md., May 12, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, announces...
10. Mai 2016 14:03 ET | Quelle: OpGen, Inc.

OpGen, Inc. Announces Timing for First Quarter Financial Results and Conference Call

GAITHERSBURG, Md., May 10, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, today...
04. Mai 2016 07:30 ET | Quelle: OpGen, Inc.

OpGen and District of Columbia Hospital Association Complete First Citywide Quantification of Multidrug-Resistant Organism (MDRO) Prevalence in Washington, D.C.-based Healthcare Facilities

Consortium of Washington, D.C. Health Organizations and OpGen test over 1,000 patient samples for antibiotic resistant bacteria OpGen’s Acuitas® detection technology provides surveillance to put...
02. Mai 2016 12:22 ET | Quelle: OpGen, Inc.

OpGen Appoints Harry J. D'Andrea to Board of Directors

GAITHERSBURG, Md., May 02, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, announces...
11. April 2016 07:30 ET | Quelle: OpGen, Inc.

New Study Data Show OpGen’s QuickFISH® Blood Culture Pathogen ID Tests to be Rapid and Cost-Effective, with Utility to Inform Antimicrobial Stewardship Decisions

GAITHERSBURG, Md., April 11, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, today...
30. März 2016 07:30 ET | Quelle: OpGen, Inc.

OpGen Announces 2015 Fourth Quarter and Full Year Financial Results

Conference call begins at 10:00 a.m. Eastern time today GAITHERSBURG, Md., March 30, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics...

Vorherige Seite